Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

12.5%

5 terminated/withdrawn out of 40 trials

Success Rate

86.8%

+0.3% vs industry average

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

21%

7 of 33 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

N/A

19(63.3%)

Early Phase 1

4(13.3%)

Phase 4

3(10.0%)

Phase 2

2(6.7%)

Phase 3

1(3.3%)

Phase 1

1(3.3%)

30Total

N/A(19)

Early Phase 1(4)

Phase 4(3)

Phase 2(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials

NCT07356986Not Yet Recruiting

Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness

Role: collaborator

NCT05444595Not ApplicableWithdrawn

Behavioral Plant-Based Dietary Intervention in Latinos

Role: collaborator

NCT06218147Not ApplicableCompleted

Community-Based Nutrition-Lifestyle Therapy for Pregnant Latina Women With Diabetes

Role: lead

NCT05000840Active Not Recruiting

Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA

Role: lead

NCT05975242Not ApplicableCompleted

Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes

Role: lead

NCT04991142Completed

Models of Nutrition From Continuous Glucose Monitors

Role: collaborator

NCT03761615Completed

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy

Role: lead

NCT05293340Not ApplicableTerminated

Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")

Role: lead

NCT04492566Not ApplicableCompleted

Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home

Role: lead

NCT04938388Phase 4Terminated

Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

Role: lead

NCT04436796Not ApplicableCompleted

The International Diabetes Closed Loop (iDCL) Trial: Protocol 4

Role: lead

NCT03668808Phase 4Completed

Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones.

Role: lead

NCT04820348Completed

Assessing Adherence to Digital Health Technologies Among Hispanic/Latino Adults With or At Risk of Type 2 Diabetes:

Role: lead

NCT03940300Not ApplicableTerminated

Farming for Life - Health Impact of Organic Vegetable Prescriptions for Adults Living With or at Risk of Type 2 Diabetes

Role: lead

NCT01613807Phase 4Completed

Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes

Role: lead

NCT03830840Completed

Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos

Role: lead

NCT01874392Not ApplicableCompleted

Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp

Role: lead

NCT01472406Early Phase 1Completed

Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)

Role: lead

NCT04016584Not ApplicableCompleted

Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy

Role: lead

NCT01484457Early Phase 1Completed

Controlled Insulin Delivery: Combining Technology With Treatment

Role: lead